Secukinumab 150 milligram [Cosentyx] ( DrugBank: Secukinumab )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
271強直性脊椎炎1

271. 強直性脊椎炎


臨床試験数 : 574 薬物数 : 359 - (DrugBank : 68) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 146
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03639740
(ClinicalTrials.gov)
January 15, 201917/8/2018Treat-to-target With Secukinumab in Axial SpondyloarthritisTReat-to-tArget (T2T) With seCukinumab in Axial Spondyloarthritis. IdEntification of MRI and Biochemical Biomarkers for Disease Activity, Treatment Response and Structural Damage Progression (the TRACE Study)Axial Spondyloarthritis;Ankylosing SpondylitisDrug: Secukinumab 150 milligram [Cosentyx]Professor Mikkel ØstergaardNovartis Healthcare A/SRecruiting18 Years70 YearsAll88Phase 4Denmark